CSIMarket
 


Genocea Biosciences Inc   (GNCA)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare

Genocea Biosciences Inc 's Working Capital Ratio

GNCA's quarterly Working Capital Ratio and Current Assets, Current Liabilities growth




GNCA Working Capital Ratio (Mar 31 2020)
I. Quarter
(Dec 31 2019)
IV. Quarter
(Sep 30 2019)
III. Quarter
(Jun 30 2019)
II. Quarter
(Mar 31 2019)
I. Quarter
Y / Y Current Liabilities Change 19.01 % -9.18 % 128.25 % 179.75 % 488.49 %
Y / Y Current Assets Change -5.89 % 53.69 % 31.73 % 31.33 % -41.22 %
Working Capital Ratio MRQ 1.98 6.62 4.33 5.96 2.51
Overall Ranking # # # # #
Seq. Current Liabilities Change 133.48 % -43.26 % 10.53 % -18.73 % 78.18 %
Seq. Current Assets Change -30.09 % -13.22 % -19.77 % 93.36 % 14.17 %



Working Capital Ratio first quarter 2020 Comment
Due to increase in Current Liabilities in the first quarter 2020, Working Capital Ratio fell to 1.98 below Genocea Biosciences Inc average.

Within Biotechnology & Drugs industry 8 other companies have achieved higher Working Capital Ratio than Genocea Biosciences Inc in first quarter 2020. While total ranking remained unchanged compare to previous quarter at no. .

Explain Working Capital Ratio
Where is GNCA most successful ?
Working Capital Ratio GNCA on the trailing twelve month basis
Working Capital Ratio first quarter 2020 Company Ranking
Within: No.
Biotechnology & Drugs Industry # 9
Healthcare Sector # 66
Overall Market # 403


Working Capital Ratio Statistics
High Average Low
78.31 17.07 1.29
(Jun 30 2016)   (Dec 31 2017)




Financial Statements
Genocea Biosciences Inc 's Current Liabilities $ 15 Millions Visit GNCA's Balance sheet
Genocea Biosciences Inc 's Current Assets $ 29 Millions Visit GNCA's Balance sheet
Source of GNCA's Sales Visit GNCA's Sales by Geography




Companies with similar Working Capital Ratio in the quarter endingMar 31 2020, within Biotechnology & Drugs Industry Working Capital RatioMar 31 2020 MRQ Current AssetsMar 31 2020 MRQ Current Liabilities
La Jolla Pharmaceutical Company  5.37 $ 86.114  Millions$ 16.047  Millions
Fennec Pharmaceuticals Inc   5.31 $ 10.123  Millions$ 1.907  Millions
Bluebird Bio Inc   5.25 $ 967.467  Millions$ 184.422  Millions
Nexien Biopharma Inc   5.24 $ 0.117  Millions$ 0.022  Millions
Cohbar Inc   5.17 $ 10.467  Millions$ 2.026  Millions
Celldex Therapeutics Inc   5.12 $ 55.918  Millions$ 10.932  Millions
Anavex Life Sciences Corp   4.98 $ 31.021  Millions$ 6.229  Millions
Gilead Sciences Inc   4.97 $ 26,950.000  Millions$ 5,422.000  Millions
Pulse Biosciences Inc   4.86 $ 16.431  Millions$ 3.383  Millions
Atyr Pharma Inc  4.82 $ 50.374  Millions$ 10.445  Millions
Frequency Therapeutics Inc   4.80 $ 209.941  Millions$ 43.728  Millions
Delmar Pharmaceuticals Inc   4.70 $ 5.099  Millions$ 1.086  Millions
Bio techne Corp  4.69 $ 491.928  Millions$ 104.985  Millions
Caladrius Biosciences Inc   4.59 $ 21.206  Millions$ 4.620  Millions
Vaxart Inc   4.52 $ 33.665  Millions$ 7.441  Millions
Seattle Genetics Inc  4.51 $ 1,160.447  Millions$ 257.219  Millions
Solid Biosciences Inc   4.50 $ 57.903  Millions$ 12.880  Millions
Orgenesis Inc   4.36 $ 112.930  Millions$ 25.910  Millions
Spero Therapeutics Inc   4.31 $ 97.960  Millions$ 22.741  Millions
Aerie Pharmaceuticals Inc   4.28 $ 338.437  Millions$ 79.145  Millions
Cue Biopharma Inc   4.23 $ 51.190  Millions$ 12.090  Millions
Eloxx Pharmaceuticals Inc   4.14 $ 45.927  Millions$ 11.084  Millions
Armata Pharmaceuticals Inc   4.05 $ 25.776  Millions$ 6.357  Millions
Aclaris Therapeutics Inc   4.01 $ 82.714  Millions$ 20.603  Millions
Akers Biosciences Inc   3.81 $ 8.296  Millions$ 2.180  Millions
Cytomx Therapeutics Inc   3.77 $ 400.066  Millions$ 106.001  Millions
Ocugen Inc   3.62 $ 11.362  Millions$ 3.138  Millions
Meridian Bioscience Inc  3.61 $ 136.589  Millions$ 37.885  Millions
Protagonist Therapeutics Inc   3.46 $ 125.986  Millions$ 36.372  Millions
Unum Therapeutics Inc   3.37 $ 31.185  Millions$ 9.250  Millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

KEM's Profile

Stock Price

KEM's Financials

Business Description

Fundamentals

Charts & Quotes

KEM's News

Suppliers

KEM's Competitors

Customers & Markets

Economic Indicators

KEM's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2020 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071